Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis.
Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results.To investigate the association between resistin and both all-cause and cardiovascular (CV) mortality risk by 1) analyzing data from the Gargano Heart Study (GHS) prospective...
Main Authors: | Andrea Fontana, Sara Spadaro, Massimiliano Copetti, Belinda Spoto, Lucia Salvemini, Patrizia Pizzini, Lucia Frittitta, Francesca Mallamaci, Fabio Pellegrini, Vincenzo Trischitta, Claudia Menzaghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4368155?pdf=render |
Similar Items
-
Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.
by: Claudia Menzaghi, et al.
Published: (2014-01-01) -
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data
by: Andrea Fontana, et al.
Published: (2017-03-01) -
Serum resistin and glomerular filtration rate in patients with type 2 diabetes.
by: Lorena Ortega Moreno, et al.
Published: (2015-01-01) -
Target values of cardiovascular risk factors are not associated with all-cause mortality in patients with type 2 diabetes mellitus.
by: Antonio Pacilli, et al.
Published: (2015-01-01) -
Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals.
by: Claudia Menzaghi, et al.
Published: (2012-01-01)